MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$398,657
Net Income
-$7,326,047
Net Profit Margin
-1837.68%
EPS
-$0.85
Unit: Dollar
Revenue Breakdown
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
398,657
985,076
447,034
627,277
Research and development
1,800,656
2,852,251
2,467,741
2,285,907
General and administrative
2,205,471
2,629,826
1,795,672
2,483,793
Sales and marketing
548,513
851,851
1,001,675
958,567
Total operating expenses
4,554,640
6,333,928
5,265,088
5,728,267
Operating loss
-4,155,983
-5,348,852
-4,818,054
-5,100,990
Grant income (loss)
-45,914
120,531
86,774
232,184
Gain on disposal of fixed assets
341
-
1,334*
0
Interest income
163
16
122
160
Interest expense
740,388
125,842
100,792*
143,800
Amortization of debt discount
405,068
450,134
374,744.5*
729,630
Loss (gain) on change in fair value of derivative liability
-1,374,076
98,642
-1,189,272.5*
304,443
Gain (loss) on change in fair value of warrant liability
1,162
13,416
91,792
27,842
Loss on extinguishment of debt
-595,500
-1,011,334
-
-
Total other income (expenses)
-3,159,280
-1,354,705
-1,484,787
-308,801
Net loss
-7,315,263
-6,703,557
-6,302,841
-5,409,791
Net loss attributable to non-controlling interest
10,784
-38,783
567,824
-
Net loss attributable to volitionrx limited stockholders
-7,326,047
-6,664,774
-5,735,017*
-
Foreign currency translation adjustments
-
134,307
-747,746*
22,348
Net comprehensive loss
-
-6,569,250
-6,482,763
-5,387,443
Diluted EPS
-0.85
-0.97
-
-0.05
Diluted Average Shares
9,154,815
6,882,744
119,925,345
108,213,068
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to volitionrx...
-$7,326,047
(-16.58%↓ Y/Y)
Net loss
-$7,315,263
(-15.86%↓ Y/Y)
Net loss
attributable to...
$10,784
(-64.04%↓ Y/Y)
Product
$398,657
(62.78%↑ Y/Y)
Operating loss
-$4,155,983
(34.01%↑ Y/Y)
Total other income
(expenses)
-$3,159,280
(-19326.18%↓ Y/Y)
Total revenues
$398,657
(-1.97%↓ Y/Y)
Gain (loss) on change
in fair value of...
$1,162
(101.85%↑ Y/Y)
Gain on disposal of
fixed assets
$341
(3.33%↑ Y/Y)
Interest income
$163
(1.88%↑ Y/Y)
Total operating
expenses
$4,554,640
(-32.07%↓ Y/Y)
Loss (gain) on change
in fair value of...
-$1,374,076
(-428.19%↓ Y/Y)
Interest expense
$740,388
(500.20%↑ Y/Y)
Loss on
extinguishment of debt
-$595,500
Amortization of debt discount
$405,068
(24.52%↑ Y/Y)
Grant income (loss)
-$45,914
(-160.42%↓ Y/Y)
General and
administrative
$2,205,471
(-25.00%↓ Y/Y)
Research and development
$1,800,656
(-33.80%↓ Y/Y)
Sales and marketing
$548,513
(-47.44%↓ Y/Y)
Buy us a coffee
VOLITIONRX LTD (VNRX)
VOLITIONRX LTD (VNRX)